DUBLIN (BUSINESS WIRE) The "Mesenchymal Stem Cells - Advances and Applications, 2022" report has been added to ResearchAndMarkets.com's offering.Today, nearly one-hundred different market competitors are developing various types of MSC-related products and services, therapies, and manufacturing technologies. Withi.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Global Mesenchymal Stem Cells Advances and Applications Market Report 2021 - ResearchAndMarkets.com
February 12, 2021 GMT
DUBLIN (BUSINESS WIRE) Feb 12, 2021
As the most common stem cell type being used within regenerative medicine today, there is huge potential for growth within the MSC market. There are more than one-hundred thousand scientific publications published about MSCs, as well as over 1,100 MSC clinical trials underway worldwide.
ADVERTISEMENT
Current “hotspots” for MSC clinical trials include the U.S., E.U., China, Middle East, and South Korea. While many early-stage MSC trials have demonstrated safety and efficacy, only a small number of MSC products have reached commercialization, indicating that the therapeutic market for MSCs remains early-stage.
Needless to say, Harvest Health & Recreation is on the list even if Robinhood and Webull users canât trade it. The bullish nature of this penny stock during 2020âs 4th quarter is hard to ignore. Itâs also one of the top penny stocks held by the MSOS ETF if youâre wondering. Since the start of October through to this week, HRVSF stock has climbed from $1.02 to $2.98. Similar to Hexo, Harvest hasnât only benefited from industry sentiment. The company has also executed on its own set of milestones and initiatives.
One of the key points of focus of traders has been the growth that Harvest experienced recently. In its last quarterly report revenue came in at $61.6 million, up 86% from the third quarter of 2019 and 11% sequentially. Adjusted EBITDA was $10.5 million, compared to $4.1 million in the second quarter of 2020. Also, as of September 30th, Harvest owned, operated, or managed 37 retail locations in seven states. This included 15 open dispensaries in Ariz